In the latest session, Cassava Sciences Inc (NASDAQ: SAVA) closed at $20.01 down -12.04% from its previous closing price of $22.75. On the day, 2100620 shares were traded.
Ratios:
For a deeper understanding of Cassava Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.13 and its Current Ratio is at 9.13. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 15, 2021, Cantor Fitzgerald Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $100.
Maxim Group reiterated its Buy rating for the stock on July 07, 2021, while the target price for the stock was revised from $80 to $190.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 23 ’23 when ROBERTSON SANFORD bought 30,000 shares for $17.45 per share. The transaction valued at 523,500 led to the insider holds 886,851 shares of the business.
Barry Richard bought 16,571 shares of SAVA for $275,907 on Aug 22 ’23. The Director now owns 293,477 shares after completing the transaction at $16.65 per share. On Aug 21 ’23, another insider, Barry Richard, who serves as the Director of the company, bought 1,906 shares for $16.80 each. As a result, the insider paid 32,021 and bolstered with 276,906 shares of the company.
Stock Price History:
Over the past 52 weeks, SAVA has reached a high of $32.10, while it has fallen to a 52-week low of $12.32.
Shares Statistics:
A total of 42.24M shares are outstanding, with a floating share count of 40.12M. Insiders hold about 7.17% of the company’s shares, while institutions hold 32.70% stake in the company.
Earnings Estimates
There are Cassava Sciences, Inc. different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $4.45, with high estimates of $61.75 and low estimates of $0.78.
Analysts are recommending an EPS of between $Consumer Cyclical and $Healthcare for the fiscal current year, implying an average EPS of $Industrials.
